National Cancer Institute; Notice of Meeting

[Federal Register Volume 64, Number 220 (Tuesday, November 16, 1999)]
[Notices]
[Pages 62210-62211]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-29883]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advanced of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(6) and 552b(c)(9), Title 5 
U.S.C., as amended. The discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the NCI 
Intramural program and/or its contractors, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy, 
and the premature disclosure of discussions related to personnel and 
programmic issues would be likely to significantly frustrate the 
subsequent implementation of recommendations.

    Name of Committee: National Cancer Advisory Board.
    Dates: December 6-8, 1999.
    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Cancer Centers.
    Open: December 6, 8:00 p.m.-Recess.
    Agenda: To discuss program and policy issues related to the 
Cancer Centers.
    Place: The Hyatt Regency Hotel, One Bethesda Metro Center, 
Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, Executive Secretary. National 
Cancer Institute, NIH, Executive Plaza North, Room 600, 6130 
Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-5147.
    Name of Committee: National Cancer Advisory Board.
    Dates: December 7-8, 1999.
    Open: December 7, 9:00 a.m. to 4:00 p.m.; December 8, 9:00 a.m. 
to 1:00 p.m.
    Agenda: Report of the Director, NCI: Overview of Board of 
Scientific Advisors activities; Intramural and Extramural Program 
Overviews and Updates; Presentations by various NCI working groups 
on current and proposed program activities, projects and 
initiatives; other NCAB business. For detailed agenda: See NCI 
Homepage/Advisory Board and Groups deainfor.nci.nih.gov/
ADVISORY/boards.htm. Tentative agenda available 10 working days 
prior to meetings; Final agenda available 5 working days prior to 
meetings.
    Closed: December 7, 4:00 p.m. to Recess.
    Agenda: To review and evaluate Intramural site visits; 
Discussion of proprietary, programmatic and personnel issues. Review 
and discussion of Extramural proprietary, programmatic and personnel 
issues.
    Place: Building 31C, Conference Room 10, National Institutes of 
Health, 3100 Center Drive, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, Executive Secretary, National 
Cancer Institute, National Institutes of Health, Executive Plaza 
North, Suite 600, 6130 Executive Boulevard, Rockville, MD 20892, 
(301) 496-5147.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


[[Page 62211]]


    Dated: November 9, 1999.
Anna Snouffer,
Acting Director, Office of Federal Advisory Policy, NIH.
[FR Doc. 99-29883 Filed 11-15-99; 8:45 am]
BILLING CODE 4140-01-M